Open original FDA record ↗Recall record
- FDA identifier
- Z-1712-2017
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA classification date
- Mar 15, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Siemens Healthcare Diagnostics has confirmed a positive bias of up to 41% in quality control and patient results for Aspartate Aminotransferase (AST) and Aspartate Aminotransferase concentrated (AST_c) assays following calibration with Advia Chemistry Enzyme 2 Calibrator lots 6JD079 and 6MD042.
Source facts
- Action
- Siemens mailed an Urgent Medical Device Correction Notice to affected customers on 02/21/2017. The notice informed calibrator customers of the reason for the correction, risk to health, and actions to be taken by customers who are in the process of converting from the fixed factor to the enzyme calibrated assay and information for customers who had already converted, until the investigation is complete.
- Initiated
- 2017-02-23
- Root cause
- Under Investigation by firm
- Terminated
- 2018-05-09
- Distribution
- Worldwide Distribution - United States Nationwide: Denmark Sweden Norway Great Britain Belgium Netherlands Spain Israel Switzerland France Portugal Greece Germany Slovenia Czech Republic Hong Kong Colombia Korea Australia
- Recall number
- Z-1712-2017
- Recall status
- Terminated
- CDRH record ID
- 153922
- FDA classified
- 2017-03-15
- Recall event number
- 76695